Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.

Klinische Pädiatrie

Volumn 221, Issue 7, 2009, Pages 425-429

  Dittrich, K ^a   Ross, S ^a   Benz, K ^a   Amann, K ^a   Dotsch J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; ARTICLE; BRAIN VASCULITIS; CHILD; DISEASE COURSE; DOSE RESPONSE; DRUG COMBINATION; FEMALE; HUMAN; LONG TERM CARE; LUPUS ERYTHEMATOSUS NEPHRITIS; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; AZATHIOPRINE; CHILD; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONG-TERM CARE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MYCOPHENOLIC ACID; PREDNISONE; RECURRENCE;

EID: 77949461986     PISSN: None     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0029-1234130     Document Type: Article

References (0)